Protease Inhibitors is a pharmacological drug class in the Mechanism of Action taxonomy containing 49 drugs such as linagliptin, desirudin, carfilzomib.

Mechanism of Action · N0000000076

Protease Inhibitors

Pharmacological class containing 49 drugs per the Mechanism of Action taxonomy.

Drugs in this class (49)

linagliptindesirudincarfilzomibnelfinaviralogliptinenalaprilat anhydrouslisinopril anhydrousindinavir anhydroussaxagliptin anhydrousbenazeprilatargatroban anhydrousdabigatranmoexiprilatquinaprilatramiprilattrandolaprilatfosinoprilatperindoprilatalirocumabevolocumabixazomibsacubitrilatgrazoprevir anhydrousbenazepriltipranavirvoxilaprevirglecaprevirlopinavircaptoprillanadelumabamprenavirberotralstatsebetralstatatazanavirquinaprilramiprilbortezomibenalapriltrandolaprildarunavirfosinoprilperindoprilsitagliptinbivalirudinecallantideC1 esterase inhibitor (human)saquinavirritonaviralpha 1-proteinase inhibitor, human

Need clinical context — common uses, side effects, or interactions for this class?

Ask GoDavaii AI about Protease Inhibitors

Common questions about Protease Inhibitors

What is the Protease Inhibitors drug class?
Protease Inhibitors is a pharmacological class in the Mechanism of Action taxonomy, classification code N0000000076. It groups 49 drugs that share a similar mechanism of action, chemical structure, or therapeutic use.
Which drugs are part of the Protease Inhibitors class?
Notable drugs in the Protease Inhibitors class include linagliptin, desirudin, carfilzomib, nelfinavir, alogliptin, and 44 more. The complete member list is shown above on this page; tap any drug name to see its full Indian-context information sheet.
What does Mechanism of Action mean?
Mechanism of Action is one of the standard taxonomies used by the NIH National Library of Medicine to organise drugs. Different taxonomies group drugs by different criteria - some by chemical structure, some by what they do in the body, some by therapeutic intent. Together these classifications make medical research, prescribing and education more consistent across the world.
Where can I get plain-language clinical context for the Protease Inhibitors class?
For plain-language clinical context - common uses, side effects, drug interactions and what the class means for an Indian patient - ask GoDavaii's Health AI. It works in 22+ Indian languages, is free and needs no signup. Tap "Ask GoDavaii AI about Protease Inhibitors" above.

Source: NIH RxClass — National Library of Medicine, public domain. Class taxonomy: Mechanism of Action. View on RxClass ↗